Most cited papers from Novo Nordisk (Denmark)
What are the most cited papers from Novo Nordisk (Denmark)?
The most cited paper from Novo Nordisk (Denmark) is "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes" (Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al., 2016), with 7,629 citations. Next come "Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes" (6,902) and "Once-Weekly Semaglutide in Adults with Overweight or Obesity" (5,049).
Showing 50 of 60 papers. Every paper with more than 903 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine | 13 Jun 2016 | 7,629 |
| 2 | Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes Steven P. Marso, Stephen Charles Bain, Agostino Consoli et al. · New England Journal of Medicine | 16 Sep 2016 | 6,902 |
| 3 | Once-Weekly Semaglutide in Adults with Overweight or Obesity John P.H. Wilding, Rachel Louise Batterham, Salvatore Calanna et al. · New England Journal of Medicine | 10 Feb 2021 | 5,049 |
| 4 | The complete genome sequence of the Gram-positive bacterium Bacillus subtilis Frank Kunst et al. · Nature | Nov 1997 | 3,720 |
| 5 | Epigenetic differences arise during the lifetime of monozygotic twins Mario Fernández Fraga et al. · Proceedings of the National Academy of Sciences | 11 Jul 2005 | 3,643 |
| 6 | A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management Xavier Pi-Sunyer, Arne Vernon Astrup, Ken Fujioka et al. · New England Journal of Medicine | Jul 2015 | 2,708 |
| 7 | Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 Thomas Ray Einarson, Annabel Acs, Craig Ludwig et al. · Cardiovascular Diabetology | 8 Jun 2018 | 2,405 |
| 8 | High-energy-physics event generation with Pythia 6.1 Torbjörn Sjöstrand, P. Edén, Christer Friberg et al. · Computer Physics Communications | Apr 2001 | 2,060 |
| 9 | Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mansoor Husain, Andreas L. Birkenfeld, Morten Donsmark et al. · New England Journal of Medicine | 11 Jun 2019 | 2,006 |
| 10 | A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis Philip Noel Newsome, Kristine Buchholtz, Kenneth J. Cusi et al. · New England Journal of Medicine | 13 Nov 2020 | 2,006 |
| 11 | Time-dependent transport in interacting and noninteracting resonant-tunneling systems Antti‐Pekka Jauho, Ned S. Wingreen, Yigal Meir · Physical review. B, Condensed matter | 15 Aug 1994 | 1,945 |
| 12 | Quark confinement and topology of gauge theories Alexander M. Polyakov · Nuclear Physics B | Mar 1977 | 1,852 |
| 13 | Glucagon-like peptide 1 (GLP-1) Timo D. Müller et al. · Molecular Metabolism | 30 Sep 2019 | 1,836 |
| 14 | Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes Vlado Perkovic, Katherine R. Tuttle, Peter R Rossing et al. · New England Journal of Medicine | 24 May 2024 | 1,815 |
| 15 | Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus Claus Morten Larsen, Mirjam V. Faulenbach, Allan Arthur Vaag et al. · New England Journal of Medicine | 11 Apr 2007 | 1,813 |
| 16 | Neural Network Ensembles, Cross Validation, and Active Learning Anders Krogh, Jesper Vedelsby | 1994 | 1,802 |
| 17 | Plasma proteomic associations with genetics and health in the UK Biobank Benjamin B. Sun et al. · Nature | 4 Oct 2023 | 1,716 |
| 18 | Astrophysical magnetic fields and nonlinear dynamo theory Axel Brandenburg, Kandaswamy Subramanian · Physics Reports | 7 Sep 2005 | 1,663 |
| 19 | Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) John B. Buse, Julio Rosenstock, Giorgio Sesti et al. · The Lancet | 9 Jun 2009 | 1,505 |
| 20 | Conformal algebra and multipoint correlation functions in 2D statistical models Vl.S. Dotsenko, Vladimir Aleksandrovich Fateev · Nuclear Physics B | Oct 1984 | 1,425 |
| 21 | Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0 Laurent Heirendt et al. · Nature Protocols | 20 Feb 2019 | 1,399 |
| 22 | Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Melanie J. Davies, Louise Færch, Ole Kleist Jeppesen et al. · The Lancet | Mar 2021 | 1,384 |
| 23 | Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity Domenica Rubino et al. · JAMA | 23 Mar 2021 | 1,377 |
| 24 | Quantum field-theoretical methods in transport theory of metals J. Rammer, H. Smith · Reviews of Modern Physics | Apr 1986 | 1,369 |
| 25 | Deciphering cell–cell interactions and communication from gene expression Erick Armingol, Adam Officer, Olivier Harismendy et al. · Nature Reviews Genetics | 9 Nov 2020 | 1,367 |
| 26 | NASH limits anti-tumour surveillance in immunotherapy-treated HCC Dominik Reinhard Pfister et al. · Nature | 24 Mar 2021 | 1,304 |
| 27 | A Simple Weight Decay Can Improve Generalization Anders Krogh, John Hertz | 1992 | 1,293 |
| 28 | Hypothalamic CART is a new anorectic peptide regulated by leptin Peter Lommer Kristensen, Martin E. Judge, Lars Thim et al. · Nature | May 1998 | 1,293 |
| 29 | The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review Susanne Fredenberg, Marie Wahlgren, Mats Reslow et al. · International Journal of Pharmaceutics | 27 May 2011 | 1,283 |
| 30 | Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage Stephan A. Mayer, Nikolai Constantin Brun, Kamilla Begtrup et al. · New England Journal of Medicine | 14 May 2008 | 1,265 |
| 31 | A serine protease triad forms the catalytic centre of a triacylglycerol lipase Leo Brady, Andrzej Marek Brzozowski, Zygmunt S. Derewenda et al. · Nature | Feb 1990 | 1,215 |
| 32 | Effect of Environmental Factors on the Kinetics of Insulin Fibril Formation: Elucidation of the Molecular Mechanism Liza Nielsen, Ritu Khurana, Alisa C. Coats et al. · Biochemistry | 24 Apr 2001 | 1,197 |
| 33 | Radiative energy loss and p⊥-broadening of high energy partons in nuclei R. Baier, Yuri L. Dokshitzer, A.H. Mueller et al. · Nuclear Physics B | 1997 | 1,184 |
| 34 | Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage Stephan A. Mayer, Nikolai Constantin Brun, Kamilla Begtrup et al. · New England Journal of Medicine | 23 Feb 2005 | 1,172 |
| 35 | Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes Melanie J. Davies, Richard M. Bergenstal, Bruce W. Bode et al. · JAMA | 18 Aug 2015 | 1,172 |
| 36 | Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study Arne Vernon Astrup, Stephan Rössner, Luc Van Gaal et al. · The Lancet | 24 Oct 2009 | 1,169 |
| 37 | Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes Michael Albrecht Nauck, Anders H. Frid, Kjeld Hermansen et al. · Diabetes Care | 17 Oct 2008 | 1,128 |
| 38 | Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide Jesper F. Lau, Paw Bloch, Lauge Schäffer et al. · Journal of Medicinal Chemistry | 26 Aug 2015 | 1,092 |
| 39 | Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity Thomas A. Wadden, Timothy Silleck Bailey, Liana K. Billings et al. · JAMA | 24 Feb 2021 | 1,078 |
| 40 | New Unstable Variants of Green Fluorescent Protein for Studies of Transient Gene Expression in Bacteria Jens Bo Andersen, Claus Sternberg, Lars Kongsbak Poulsen et al. · Applied and Environmental Microbiology | Jun 1998 | 1,078 |
| 41 | Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension John P.H. Wilding, Rachel Louise Batterham, Melanie J. Davies et al. · Diabetes Obesity and Metabolism | 19 Apr 2022 | 1,066 |
| 42 | Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial Alan J. Garber, Robert R. Henry, Robert E. Ratner et al. · The Lancet | 25 Sep 2008 | 1,058 |
| 43 | BiGG Models: A platform for integrating, standardizing and sharing genome-scale models Zachary A. King, Justin S. Lu, Andreas Dräger et al. · Nucleic Acids Research | 17 Oct 2015 | 1,053 |
| 44 | Exchange-correlation energy of a metallic surface: Wave-vector analysis David C. Langreth, John P. Perdew · Physical review. B, Solid state | 15 Mar 1977 | 1,052 |
| 45 | Bound state properties of Borromean halo nuclei: 6He and 11Li Maxim Vitalievich Zhukov, B. V. Danilin, Daniil V. Fedorov et al. · Physics Reports | Aug 1993 | 1,033 |
| 46 | FDA-approved small-molecule kinase inhibitors Peng Wu, Thomas E. Nielsen, Mads H. Clausen · Trends in Pharmacological Sciences | 12 May 2015 | 1,031 |
| 47 | Radiative energy loss of high energy quarks and gluons in a finite-volume quark-gluon plasma R. Baier, Yuri L. Dokshitzer, Alfred H. Mueller et al. · Nuclear Physics B | 1997 | 1,025 |
| 48 | GALACTIC MAGNETISM: Recent Developments and Perspectives Rainer Beck, Axel Brandenburg, David L. Moss et al. · Annual Review of Astronomy and Astrophysics | Sep 1996 | 1,014 |
| 49 | Interatomic interactions in the effective-medium theory Karsten W. Jacobsen, Jens K. Nørskov, Martti J. Puska · Physical review. B, Condensed matter | 15 May 1987 | 985 |
| 50 | Qualitative research and content validity: developing best practices based on science and experience Meryl I. Brod, Laura E. Tesler, Torsten L. Christensen · Quality of Life Research | 26 Sep 2009 | 970 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.